Table of Contents

2019-2024 Global Parkinson Disease Drug Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Parkinson Disease Drug Market Size 2014-2024
2.1.2 Parkinson Disease Drug Market Size CAGR by Region
2.2 Parkinson Disease Drug Segment by Type
2.2.1 Sinemet-CR
2.2.2 Trastal
2.2.3 Madopar
2.2.4 COMT Inhibitor
2.2.5 Other
2.3 Parkinson Disease Drug Market Size by Type
2.3.1 Global Parkinson Disease Drug Market Size Market Share by Type (2014-2019)
2.3.2 Global Parkinson Disease Drug Market Size Growth Rate by Type (2014-2019)
2.4 Parkinson Disease Drug Segment by Application
2.4.1 Under 40 Years Old
2.4.2 40-65 Years Old
2.4.3 Above 65 Years Old
2.5 Parkinson Disease Drug Market Size by Application
2.5.1 Global Parkinson Disease Drug Market Size Market Share by Application (2014-2019)
2.5.2 Global Parkinson Disease Drug Market Size Growth Rate by Application (2014-2019)

3 Global Parkinson Disease Drug by Players
3.1 Global Parkinson Disease Drug Market Size Market Share by Players
3.1.1 Global Parkinson Disease Drug Market Size by Players (2017-2019)
3.1.2 Global Parkinson Disease Drug Market Size Market Share by Players (2017-2019)
3.2 Global Parkinson Disease Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Parkinson Disease Drug by Regions
4.1 Parkinson Disease Drug Market Size by Regions
4.2 Americas Parkinson Disease Drug Market Size Growth
4.3 APAC Parkinson Disease Drug Market Size Growth
4.4 Europe Parkinson Disease Drug Market Size Growth
4.5 Middle East & Africa Parkinson Disease Drug Market Size Growth

5 Americas
5.1 Americas Parkinson Disease Drug Market Size by Countries
5.2 Americas Parkinson Disease Drug Market Size by Type
5.3 Americas Parkinson Disease Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Parkinson Disease Drug Market Size by Countries
6.2 APAC Parkinson Disease Drug Market Size by Type
6.3 APAC Parkinson Disease Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Parkinson Disease Drug by Countries
7.2 Europe Parkinson Disease Drug Market Size by Type
7.3 Europe Parkinson Disease Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Parkinson Disease Drug by Countries
8.2 Middle East & Africa Parkinson Disease Drug Market Size by Type
8.3 Middle East & Africa Parkinson Disease Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Parkinson Disease Drug Market Forecast
10.1 Global Parkinson Disease Drug Market Size Forecast (2019-2024)
10.2 Global Parkinson Disease Drug Forecast by Regions
10.2.1 Global Parkinson Disease Drug Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Parkinson Disease Drug Forecast by Type
10.8 Global Parkinson Disease Drug Forecast by Application

11 Key Players Analysis
11.1 Merck
11.1.1 Company Details
11.1.2 Parkinson Disease Drug Product Offered
11.1.3 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Merck News
11.2 Akorn
11.2.1 Company Details
11.2.2 Parkinson Disease Drug Product Offered
11.2.3 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Akorn News
11.3 GSK
11.3.1 Company Details
11.3.2 Parkinson Disease Drug Product Offered
11.3.3 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 GSK News
11.4 Novartis
11.4.1 Company Details
11.4.2 Parkinson Disease Drug Product Offered
11.4.3 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Novartis News
11.5 Boehringer Ingelheim
11.5.1 Company Details
11.5.2 Parkinson Disease Drug Product Offered
11.5.3 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Boehringer Ingelheim News
11.6 Teva Pharmaceutical
11.6.1 Company Details
11.6.2 Parkinson Disease Drug Product Offered
11.6.3 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Teva Pharmaceutical News
11.7 Abbvie
11.7.1 Company Details
11.7.2 Parkinson Disease Drug Product Offered
11.7.3 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Abbvie News
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Company Details
11.8.2 Parkinson Disease Drug Product Offered
11.8.3 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Kyowa Hakko Kirin Pharma News
11.9 Astellas Pharma
11.9.1 Company Details
11.9.2 Parkinson Disease Drug Product Offered
11.9.3 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Astellas Pharma News
11.10 Desitin Arzneimittel
11.10.1 Company Details
11.10.2 Parkinson Disease Drug Product Offered
11.10.3 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Desitin Arzneimittel News
11.11 Endo Pharmaceuticals
11.12 F.Hoffmann-La Roche
11.13 H.Lundbeck
11.14 Valeant
11.15 Apokyn
11.16 Orion
11.17 Stada Arzneimittel
11.18 US WorldMeds
11.19 Valeant Pharmaceuticals

12 Research Findings and Conclusion